Cargando…

Screening for colorectal cancer with immunological FOBT

Detalles Bibliográficos
Autores principales:	Ottó, S, Döbrössy, L
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409729/ https://www.ncbi.nlm.nih.gov/pubmed/15150617 http://dx.doi.org/10.1038/sj.bjc.6601798

Ejemplares similares

Reply: Screening for colorectal cancer with immunological FOBT
por: Saito, Hiroshi, et al.
Publicado: (2004)

Prescreening with FOBT Improves Yield and Is Cost-Effective in Colorectal Screening in the Elderly
por: Singhal, Shashideep, et al.
Publicado: (2014)

The effectiveness of FOBT vs. FIT: A meta-analysis on colorectal cancer screening test
por: Mousavinezhad, Maryam, et al.
Publicado: (2016)

Diagnostic Value of Combining miRNAs, CEA Measurement and the FOBT in Colorectal Cancer Screening
por: Li, Xiaodan, et al.
Publicado: (2020)

Colorectal Cancer Screening Among Adults in Zuni Pueblo: Factors Associated with FOBT and Colonoscopy Utilization
por: Edwardson, Nicholas, et al.
Publicado: (2023)

CT colonography with limited bowel preparation for the detection of colorectal neoplasia in an FOBT positive screening population
por: Liedenbaum, Marjolein H., et al.
Publicado: (2009)

Report on the Dutch Consensus Development Meeting for Implementation and Further Development of Population Screening for Colorectal Cancer Based on FOBT
por: de Visser, M., et al.
Publicado: (2005)

Investigating Factors Associated with FOBT Screening for Colorectal Cancer Based on the Components of Health Belief Model and Social Support
por: Jeihooni, Ali Khani, et al.
Publicado: (2017)

Directly Mailing gFOBT Kits to Previous Responders Being Recalled for Colorectal Cancer Screening Increases Participation
por: Tinmouth, Jill, et al.
Publicado: (2020)

Physician‐office vs home uptake of colorectal cancer screening using FOBT/FIT among screening‐eligible US adults
por: Chido‐Amajuoyi, Onyema Greg, et al.
Publicado: (2019)

Colorectal cancer screening using the faecal occult blood test (FOBt): a survey of GP attitudes and practices in the UK
por: Damery, Sarah, et al.
Publicado: (2010)

Diagnostic Accuracy of FOBT and Colorectal Cancer Genetic Testing: A Systematic Review & Meta-Analysis
por: Ramdzan, Abdul Rahman, et al.
Publicado: (2019)

Screening for colorectal cancer with FOBT, virtual colonoscopy and optical colonoscopy: study protocol for a randomized controlled trial in the Florence district (SAVE study)
por: Sali, Lapo, et al.
Publicado: (2013)

Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme
por: Ciatto, S, et al.
Publicado: (2007)

Attitudes towards the Faecal Occult Blood Test (FOBT) versus the Faecal Immunochemical Test (FIT) for colorectal cancer screening: perceived ease of completion and disgust
por: Chambers, Julie A., et al.
Publicado: (2016)

Die optimale Zeitspanne zwischen positivem FOBT und einer Abklärungskoloskopie
por: Pox, Christian Peter
Publicado: (2022)

Patienten mit positivem iFOBT müssen rasch zur Koloskopie
por: Pox, Christian Peter
Publicado: (2022)

Colorectal cancer mortality 10 years after a single round of guaiac faecal occult blood test (gFOBT) screening: experiences from a Danish screening cohort
por: Bjerrum, Andreas, et al.
Publicado: (2016)

Cost-effectiveness of population-based screening for colorectal cancer
por: O'Mahony, J F
Publicado: (2013)

Colonoscopy colorectal cancer screening: Cost-effectiveness in Thailand
por: Joob, Beuy, et al.
Publicado: (2016)

Is colorectal cancer screening necessary before 50 years of age?
por: Jung, Yoon Suk
Publicado: (2017)

Advocacy for colorectal cancer screening and awareness in people with intellectual disability
por: Satgé, Daniel, et al.
Publicado: (2023)

The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands
por: Dinmohamed, Avinash G., et al.
Publicado: (2020)

Immunological detection of occult blood in faeces in colorectal cancer.
por: St John, D. J., et al.
Publicado: (1984)

Preservation of bacterial DNA in 10-year-old guaiac FOBT cards and FIT tubes
por: Couto Furtado Albuquerque, Matheus, et al.
Publicado: (2017)

Reducing the need for colonoscopy with adjusted FIT and FOBT for stool weight and serum Hb levels
por: Ghomashi, Niousha, et al.
Publicado: (2023)

Using of artificial intelligence: Current and future applications in colorectal cancer screening
por: Zacharakis, Georgios, et al.
Publicado: (2022)

A New Risk-Scoring System for Colorectal Cancer and Polyp Screening
por: Romanová, Alexandra, et al.
Publicado: (2022)

tRNA‐derived fragments are promising biomarkers for screening of early colorectal cancer
por: Dang, Yanqi, et al.
Publicado: (2023)

Immunologic characterization of COVID-19 patients with hematological cancer
por: Maia, Catarina, et al.
Publicado: (2020)

Reply: cost-effectiveness of population-based screening for colorectal cancer
por: Sharp, L, et al.
Publicado: (2013)

Colorectal screening: We have not caught up. A surge of colorectal cancer after the coronavirus disease 2019 (COVID-19) pandemic?
por: Challine, Alexandre, et al.
Publicado: (2021)

CRITICAL APPRAISAL OF THE CLINICAL TRIAL: EFFECT OF COLONOSCOPY SCREENING ON RISKS OF COLORECTAL CANCER AND RELATED DEATH
por: Bernardo, Wanderley Marques, et al.
Publicado: (2023)

Re: “Colorectal screening: We have not caught up. A surge of colorectal cancer after the coronavirus disease 2019 (COVID-19) pandemic?”
por: Mak, Victoria P., et al.
Publicado: (2021)

Ethical dilemma of colorectal screening: What age should a screening colonoscopy start and stop?
por: Turshudzhyan, Alla, et al.
Publicado: (2021)

New faecal tests for colorectal cancer screening: is tumour pyruvate kinase M2 one of the options?
por: Shastri, Y M, et al.
Publicado: (2007)

Proteus syndrome: evaluation of the immunological profile
por: Lougaris, Vassilios, et al.
Publicado: (2016)

Reply: New faecal tests for colorectal cancer screening: is tumour pyruvate kinase M2 one of the options?
por: Haug, U, et al.
Publicado: (2007)

Adjuvant treatment in colorectal cancer
por: Taal, B G, et al.
Publicado: (2002)

Transplantation immunology
por: Burlingham, William J.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_bif3a5i35khvqt2an3akv704ul